87. Pulmonary veno-occlusive disease Clinical trials / Disease details


Clinical trials : 3 Drugs : 4 - (DrugBank : 3) / Drug target genes : 4 - Drug target pathways : 45

  
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-UMIN000020543
2015/03/0113/01/2016Efficacy of imatinib for the treatment of pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosisEfficacy of imatinib for the treatment of pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis - Efficacy of imatinib for the treatment of pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosisOral administration of imatinibNational Hospital Organization Okayama Medical CenterNULLComplete: follow-up complete18years-oldNot applicableMale and Female8Not applicableJapan
2NCT00891527
(ClinicalTrials.gov)
October 200830/4/2009Pilot Study Using Avastin and Gleevec to Treat the Progression of Intraluminal Pulmonary Vein StenosisAdjunct Targeted Biologic Inhibition in Children With Multivessel Intraluminal Pulmonary Vein StenosisPulmonary Veno Occlusive DiseaseDrug: Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec)Boston Children's HospitalNULLCompletedN/AN/AAll50Phase 1/Phase 2United States
3NCT00563498
(ClinicalTrials.gov)
July 200421/11/2007Effects on Glutamine on the Outcome of Allogeneic Bone Marrow Transplant RecipientsA Randomized Control Studies on the Effects of Glutamine on the Clinical Outcome of Bone Marrow Transplant Recipients With Special Reference to Veno-occlusive Disease and Mucositis.Pulmonary Veno-Occlusive Disease;Hepatic Veno-Occlusive Disease;MucositisDrug: GlutamineHospital Authority, Hong KongThe University of Hong Kong;Fresienius Kabi HK LtdRecruiting18 YearsN/ABoth40N/AChina